CAS 111358-88-4
:Lestaurtinib
Description:
Lestaurtinib, with the CAS number 111358-88-4, is a small molecule that functions primarily as a protein kinase inhibitor. It is particularly noted for its activity against the FLT3 (Fms-like tyrosine kinase 3) receptor, which is often mutated in certain types of leukemia, especially acute myeloid leukemia (AML). The compound is characterized by its ability to interfere with cellular signaling pathways that promote cell proliferation and survival, making it a candidate for targeted cancer therapies. Lestaurtinib has been investigated in clinical trials for its efficacy in treating hematological malignancies. In terms of its chemical structure, it features a complex arrangement that includes various functional groups, contributing to its biological activity. The substance is typically administered in a pharmaceutical context, and its safety and efficacy profiles are evaluated through rigorous clinical testing. As with many kinase inhibitors, potential side effects may include impacts on normal cellular functions, necessitating careful monitoring during treatment.
Formula:C26H21N3O4
InChI:InChI=1/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18?,25-,26-/m0/s1
InChI key:InChIKey=UIARLYUEJFELEN-LROUJFHJSA-N
SMILES:C[C@]12N3C=4C=5N(C=6C(C5C7=C(C4C=8C3=CC=CC8)CNC7=O)=CC=CC6)[C@](O1)(C[C@@]2(CO)O)[H]
Synonyms:- (5S,6S)-6-hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacen-13-one
- (5S,6S,8R)-6-hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacen-13-one
- (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:321kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one
- (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one
- 9,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-
- 9,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, [9S-(9α,10β,12α)]-
- A 154475.0
- Cep 701
- Kt 5555
- NSC 621867
- Sp 924
- (9S-(9α,10β,12α))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxyMethyl)-9-Methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one
- CEP-701 hydrate
- KT-5555 hydrate
- lestaurtinib
- Apalutamide
- SPM-924
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Lestaurtinib
CAS:Formula:C26H21N3O4Purity:≥ 98.0%Color and Shape:White to off-white solidMolecular weight:439.47Lestaurtinib
CAS:LestaurtinibFormula:C26H21N3O4Purity:By hplc: 98.43% (Typical Value in Batch COA)Color and Shape: white powderMolecular weight:439.46g/molLestaurtinib
CAS:Lestaurtinib (CEP 701) is a FLT3 inhibitor that inhibits the phosphorylation of RPTKs and can be used to study leukemia.Formula:C26H21N3O4Purity:99.17%Color and Shape:Off-White SolidMolecular weight:439.46Lestaurtinib
CAS:Lestaurtinib is a multitarget tyrosine kinase inhibitor of the JAK, FLT-3 and TrkA families of tyrosine kinases at nanomolar concentrations. It inhibits proliferation and induces apoptosis in vitro. Lestaurtinib is a FDA approved orphan drug for acute myeloid leukemia.Formula:C26H21N3O4Purity:Min. 95%Color and Shape:PowderMolecular weight:439.46 g/molLestaurtinib
CAS:Controlled Product<p>Stability Photosensitive<br>Applications It is used for the treatment of pancreatic cancer and acute myelogenous leukaemia (AML).<br></p>Formula:C26H21N3O4Color and Shape:NeatMolecular weight:439.46





